Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems

Table 2 Different expression of c-Jun, N-ras, Caspase9 and p73 in different clinical stages of thymoma n (%)

		Stage I N = 21	Stage II N = 20	Stage III N = 15	Stage IV N = 4	Total N = 60	P ^a	P ^b	P ^c	P ^d
C-Jun	+	6 (28.6)	4 (20.0)	8 (53.3)	4 (100.0)	22 (36.7)	0.009	0.004	0.523	0.245
N-ras	+	3 (14.3)	3 (15.0)	6 (40.0)	0 (0)	12 (20.0)	0.184
Caspase9	+	8 (38.1)	11 (55.0)	8 (53.3)	3 (75.0)	30 (50.0)	0.482
p73	+	6 (28.6)	10 (50.0)	9 (60.0)	3 (75.0)	28(46.6)	0.089

P^a: Two-sided Fisher’s exact test for distributions between different stages of TETs.
P^b: Two-sided Fisher’s exact test for distributions between stage III + IV and stage I + II of TETs.
P^c: Two-sided Fisher’s exact test for distributions between stage I and stage II of TETs.
P^d: Two-sided Fisher’s exact test for distributions between stage III and stage IV of TETs.

ISSN: 1746-1596